Connection

HUI-LIN PAN to Spinal Cord

This is a "connection" page, showing publications HUI-LIN PAN has written about Spinal Cord.
Connection Strength

10.765
  1. Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain. J Biol Chem. 2022 06; 298(6):101999.
    View in: PubMed
    Score: 0.620
  2. Theta-Burst Stimulation of Primary Afferents Drives Long-Term Potentiation in the Spinal Cord and Persistent Pain via a2d-1-Bound NMDA Receptors. J Neurosci. 2022 01 19; 42(3):513-527.
    View in: PubMed
    Score: 0.604
  3. Streptozotocin-Induced Diabetic Neuropathic Pain Is Associated with Potentiated Calcium-Permeable AMPA Receptor Activity in the Spinal Cord. J Pharmacol Exp Ther. 2019 11; 371(2):242-249.
    View in: PubMed
    Score: 0.516
  4. Presynaptic NMDA receptors control nociceptive transmission at the spinal cord level in neuropathic pain. Cell Mol Life Sci. 2019 May; 76(10):1889-1899.
    View in: PubMed
    Score: 0.498
  5. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord. Neuropharmacology. 2017 Sep 01; 123:477-487.
    View in: PubMed
    Score: 0.444
  6. Casein kinase II regulates N-methyl-D-aspartate receptor activity in spinal cords and pain hypersensitivity induced by nerve injury. J Pharmacol Exp Ther. 2014 Aug; 350(2):301-12.
    View in: PubMed
    Score: 0.359
  7. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. J Pharmacol Exp Ther. 2014 May; 349(2):239-47.
    View in: PubMed
    Score: 0.353
  8. Nerve injury increases GluA2-lacking AMPA receptor prevalence in spinal cords: functional significance and signaling mechanisms. J Pharmacol Exp Ther. 2013 Dec; 347(3):765-72.
    View in: PubMed
    Score: 0.341
  9. Functional plasticity of group II metabotropic glutamate receptors in regulating spinal excitatory and inhibitory synaptic input in neuropathic pain. J Pharmacol Exp Ther. 2011 Jan; 336(1):254-64.
    View in: PubMed
    Score: 0.278
  10. Opioid-induced long-term potentiation in the spinal cord is a presynaptic event. J Neurosci. 2010 Mar 24; 30(12):4460-6.
    View in: PubMed
    Score: 0.268
  11. Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats. J Neurochem. 2009 Nov; 111(4):1000-10.
    View in: PubMed
    Score: 0.259
  12. Signaling mechanisms mediating muscarinic enhancement of GABAergic synaptic transmission in the spinal cord. Neuroscience. 2009 Feb 18; 158(4):1577-88.
    View in: PubMed
    Score: 0.245
  13. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J Neurochem. 2009 Jan; 108(1):305-18.
    View in: PubMed
    Score: 0.244
  14. Sustained inhibition of neurotransmitter release from nontransient receptor potential vanilloid type 1-expressing primary afferents by mu-opioid receptor activation-enkephalin in the spinal cord. J Pharmacol Exp Ther. 2008 Nov; 327(2):375-82.
    View in: PubMed
    Score: 0.239
  15. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception. Neuropharmacology. 2008 Aug; 55(2):215-22.
    View in: PubMed
    Score: 0.236
  16. Potentiation of spinal alpha(2)-adrenoceptor analgesia in rats deficient in TRPV1-expressing afferent neurons. Neuropharmacology. 2007 Jun; 52(8):1624-30.
    View in: PubMed
    Score: 0.218
  17. Regulation of glutamate release from primary afferents and interneurons in the spinal cord by muscarinic receptor subtypes. J Neurophysiol. 2007 Jan; 97(1):102-9.
    View in: PubMed
    Score: 0.211
  18. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids. Brain Res. 2006 Apr 07; 1081(1):119-25.
    View in: PubMed
    Score: 0.202
  19. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol. 2006 May; 95(5):3086-96.
    View in: PubMed
    Score: 0.202
  20. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain. J Pharmacol Exp Ther. 2005 Nov; 315(2):696-703.
    View in: PubMed
    Score: 0.194
  21. Systemic morphine inhibits dorsal horn projection neurons through spinal cholinergic system independent of descending pathways. J Pharmacol Exp Ther. 2005 Aug; 314(2):611-7.
    View in: PubMed
    Score: 0.191
  22. Regulation of synaptic inputs to paraventricular-spinal output neurons by alpha2 adrenergic receptors. J Neurophysiol. 2005 Jan; 93(1):393-402.
    View in: PubMed
    Score: 0.183
  23. Activation of mu-opioid receptors excites a population of locus coeruleus-spinal neurons through presynaptic disinhibition. Brain Res. 2004 Jan 30; 997(1):67-78.
    View in: PubMed
    Score: 0.175
  24. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology. 2003 Dec; 99(6):1409-14.
    View in: PubMed
    Score: 0.173
  25. mGluR5 from Primary Sensory Neurons Promotes Opioid-Induced Hyperalgesia and Tolerance by Interacting with and Potentiating Synaptic NMDA Receptors. J Neurosci. 2023 08 02; 43(31):5593-5607.
    View in: PubMed
    Score: 0.169
  26. Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats. Brain Res. 2003 Mar 07; 965(1-2):67-74.
    View in: PubMed
    Score: 0.165
  27. Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via a2d-1-Dependent Presynaptic NMDA Receptors. J Neurosci. 2022 12 14; 42(50):9315-9329.
    View in: PubMed
    Score: 0.161
  28. Nitric oxide inhibits spinally projecting paraventricular neurons through potentiation of presynaptic GABA release. J Neurophysiol. 2002 Nov; 88(5):2664-74.
    View in: PubMed
    Score: 0.161
  29. Activation of delta-opioid receptors excites spinally projecting locus coeruleus neurons through inhibition of GABAergic inputs. J Neurophysiol. 2002 Nov; 88(5):2675-83.
    View in: PubMed
    Score: 0.161
  30. Inhibition of glutamatergic synaptic input to spinal lamina II(o) neurons by presynaptic alpha(2)-adrenergic receptors. J Neurophysiol. 2002 Apr; 87(4):1938-47.
    View in: PubMed
    Score: 0.154
  31. Epigenetic Mechanisms of Neural Plasticity in Chronic Neuropathic Pain. ACS Chem Neurosci. 2022 02 16; 13(4):432-441.
    View in: PubMed
    Score: 0.153
  32. Calcineurin Regulates Synaptic Plasticity and Nociceptive Transmission at the Spinal Cord Level. Neuroscientist. 2022 12; 28(6):628-638.
    View in: PubMed
    Score: 0.150
  33. Spinal endogenous acetylcholine contributes to the analgesic effect of systemic morphine in rats. Anesthesiology. 2001 Aug; 95(2):525-30.
    View in: PubMed
    Score: 0.147
  34. a2d-1 switches the phenotype of synaptic AMPA receptors by physically disrupting heteromeric subunit assembly. Cell Rep. 2021 07 20; 36(3):109396.
    View in: PubMed
    Score: 0.147
  35. Role of spinal muscarinic and nicotinic receptors in clonidine-induced nitric oxide release in a rat model of neuropathic pain. Brain Res. 2000 Apr 10; 861(2):390-8.
    View in: PubMed
    Score: 0.135
  36. Histone methyltransferase G9a diminishes expression of cannabinoid CB1 receptors in primary sensory neurons in neuropathic pain. J Biol Chem. 2020 03 13; 295(11):3553-3562.
    View in: PubMed
    Score: 0.133
  37. Spinal cyclooxygenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience. 2000; 97(4):743-8.
    View in: PubMed
    Score: 0.132
  38. Intrathecal S-nitroso-N-acetylpenicillamine and L-cysteine attenuate nerve injury-induced allodynia through noradrenergic activation in rats. Neuroscience. 2000; 101(3):759-65.
    View in: PubMed
    Score: 0.132
  39. a2d-1-Bound N-Methyl-D-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents. Anesthesiology. 2019 05; 130(5):804-819.
    View in: PubMed
    Score: 0.126
  40. Intrathecal clonidine alleviates allodynia in neuropathic rats: interaction with spinal muscarinic and nicotinic receptors. Anesthesiology. 1999 Feb; 90(2):509-14.
    View in: PubMed
    Score: 0.124
  41. Role of spinal NO in antiallodynic effect of intrathecal clonidine in neuropathic rats. Anesthesiology. 1998 Dec; 89(6):1518-23.
    View in: PubMed
    Score: 0.122
  42. Role of spinal NK1 receptors in cardiovascular responses to chemical stimulation of the gallbladder. Am J Physiol. 1995 Feb; 268(2 Pt 2):H526-34.
    View in: PubMed
    Score: 0.094
  43. Increased spinal cord Na?-K?-2Cl? cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain. J Biol Chem. 2014 Nov 07; 289(45):31111-20.
    View in: PubMed
    Score: 0.092
  44. Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain. J Pharmacol Exp Ther. 2013 Apr; 345(1):161-8.
    View in: PubMed
    Score: 0.082
  45. Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice. J Biol Chem. 2010 Dec 24; 285(52):40427-37.
    View in: PubMed
    Score: 0.070
  46. Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain. J Neurochem. 2010 Jan; 112(1):162-72.
    View in: PubMed
    Score: 0.065
  47. Stimulation of alpha(1)-adrenoceptors reduces glutamatergic synaptic input from primary afferents through GABA(A) receptors and T-type Ca(2+) channels. Neuroscience. 2009 Feb 18; 158(4):1616-24.
    View in: PubMed
    Score: 0.061
  48. Increased C-fiber nociceptive input potentiates inhibitory glycinergic transmission in the spinal dorsal horn. J Pharmacol Exp Ther. 2008 Mar; 324(3):1000-10.
    View in: PubMed
    Score: 0.057
  49. Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats. J Physiol. 2006 Mar 01; 571(Pt 2):403-13.
    View in: PubMed
    Score: 0.050
  50. Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther. 2005 May; 313(2):765-70.
    View in: PubMed
    Score: 0.047
  51. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons. J Pharmacol Exp Ther. 2004 May; 309(2):476-83.
    View in: PubMed
    Score: 0.044
  52. Activation of muscarinic receptors inhibits spinal dorsal horn projection neurons: role of GABAB receptors. Neuroscience. 2004; 125(1):141-8.
    View in: PubMed
    Score: 0.044
  53. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. J Pharmacol Exp Ther. 2003 Nov; 307(2):676-81.
    View in: PubMed
    Score: 0.043
  54. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci. 2003 Jun 15; 23(12):5041-9.
    View in: PubMed
    Score: 0.042
  55. S-nitroso-l-cysteine releases norepinephrine in rat spinal synaptosomes. Brain Res. 2000 Jul 28; 872(1-2):301-7.
    View in: PubMed
    Score: 0.034
  56. Norepinephrine release from spinal synaptosomes: auto-alpha2 -adrenergic receptor modulation. Anesthesiology. 2000 Jul; 93(1):164-72.
    View in: PubMed
    Score: 0.034
  57. 6-NO(2)-norepinephrine increases norepinephrine release and inhibits norepinephrine uptake in rat spinal synaptosomes. J Pharmacol Exp Ther. 2000 Mar; 292(3):895-9.
    View in: PubMed
    Score: 0.033
  58. Formation of 6-nitro-norepinephrine from nitric oxide and norepinephrine in the spinal cord and its role in spinal analgesia. Neuroscience. 2000; 101(1):189-96.
    View in: PubMed
    Score: 0.033
  59. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism. J Neurophysiol. 1997 Oct; 78(4):2072-8.
    View in: PubMed
    Score: 0.028
  60. Role of ATP-sensitive potassium channels in modulating nociception in rat model of bone cancer pain. Brain Res. 2014 Mar 20; 1554:29-35.
    View in: PubMed
    Score: 0.022
  61. Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease. Nat Neurosci. 2014 Feb; 17(2):232-9.
    View in: PubMed
    Score: 0.022
  62. Control of glycinergic input to spinal dorsal horn neurons by distinct muscarinic receptor subtypes revealed using knockout mice. J Pharmacol Exp Ther. 2007 Dec; 323(3):963-71.
    View in: PubMed
    Score: 0.014
  63. Opposing functions of spinal M2, M3, and M4 receptor subtypes in regulation of GABAergic inputs to dorsal horn neurons revealed by muscarinic receptor knockout mice. Mol Pharmacol. 2006 Mar; 69(3):1048-55.
    View in: PubMed
    Score: 0.012
  64. Antinociceptive and hemodynamic effects of a novel alpha2-adrenergic agonist, MPV-2426, in sheep. Anesthesiology. 1999 Nov; 91(5):1425-36.
    View in: PubMed
    Score: 0.008
  65. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats. Anesthesiology. 1999 Oct; 91(4):1072-9.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.